Black Diamond Therapeutics, Inc

Q3 2024 13F Holders

Symbol
BDTX
CUSIP
09203E105
Type
Equity
Class
COM
Num filings
117
Total reported value, excl. options
$212 M
Manager Report Date Value ($000) Shares Option Type